Publications by authors named "Christopher Su"

Claim this Profile
A
Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.
Manuel R Espinoza-Gutarra, Jennifer Collins, Vanessa Kennedy, Jill Randall, Christopher T Su, Anthony Sung

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Personal Credit Data With Financial Hardship and Treatment Outcomes in Patients With Multiple Myeloma.
Christopher T Su, Rahul Banerjee, Li Li, Catherine Fedorenko, Andrew Cowan

Clin Lymphoma Myeloma Leuk· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can We Use Credit Data to Assess Cancer Financial Hardship?
Christopher T Su, Scott D Ramsey, Veena Shankaran

JAMA Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of social vulnerability index and chimeric antigen receptor T-cell therapy administration, 2018-2023.
Alireza Boloori, Emisa Nategh, Christopher T Su

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102).
Christopher T Su, Wael Saber, Aasthaa Bansal, Li Li, Ryotaro Nakamura

Transplant Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-184: Association of Chimeric Antigen Receptor T-Cell Therapy and Social Vulnerability Index: A National View of Care Delivery Patterns.
Christopher T Su, Emisa Nategh, Alireza Boloori

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating time toxicity in lymphoma and multiple myeloma.
Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee

Leuk Lymphoma· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.
Rahul Banerjee, Andrew J Cowan, Marivel Ortega, Constance Missimer, Paul A Carpenter, Masumi Ueda Oshima, Christopher T Su

Clin Lymphoma Myeloma Leuk· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Debt-An Iatrogenic Epidemic With Mortal Consequences.
Christopher T Su, Scott D Ramsey

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital symptom assessment tools: the next frontier in financial toxicity screening.
Christopher T Su, Veena Shankaran

Nat Rev Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways.
Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma, Christopher Su

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data.
Christopher T Su, Jason C Chen, Jeremy B Sussman

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar

Prostate· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Role of the Modern Oncology Provider in Mitigating Financial Toxicity.
Christopher T Su, Veena Shankaran

J Am Coll Radiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma.
Charles B Nguyen, Christopher T Su, Meredith Morgan, Ajjai S Alva

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.
Christopher T Su

JCO Oncol Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, Chih-Yuan Hsu, Yu Shyr, Sumit A Shah, Christopher Su

Blood Cancer Discov· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Activity of PARP Inhibitors in - Versus -Altered Metastatic Castration-Resistant Prostate Cancer.
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Christopher Su

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Christopher T Su, Arnab Basu, Sumit A Shah

Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium.
Arielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, Samuel M Rubinstein, Elizabeth Wulff-Burchfield, Christopher T Su

Lancet Healthy Longev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020.
Christopher T Su, Christine M Veenstra, Minal R Patel

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
Catherine Curran, Elio Adib, Vera Kazakova, Petros Grivas, Leonidas Nikolaos Diamantopoulos, Christopher Su

Clin Genitourin Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affordable Care Act and Cancer Survivors' Financial Barriers to Care: Analysis of the National Health Interview Survey, 2009-2018.
Christopher T Su, Dolorence Okullo, Stephanie Hingtgen, Deborah A Levine, Susan D Goold

JCO Oncol Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.
Christopher T Su, J Christine Ye

J Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, Samuel M Rubinstein, Michael J Joyner, Christopher T Su

JAMA Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis